← Back to patent-cliff list
Deuterated vortioxetine
Tier C — Watch / tradeDeuterated vortioxetine
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：SERT, DAT, NET
Indications (approved)：Depressive disorder, Major depressive disorder, Depression
Regional status
US
-
EU
-
China
Phase III
2024-05-27
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Deuterated vortioxetine?
Approved indications include: Depressive disorder, Major depressive disorder, Depression.
When does the Deuterated vortioxetine patent expire?
No public expiry year is available for Deuterated vortioxetine yet; this page updates once verified.
How do I get a quote for Deuterated vortioxetine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01